Market Research Logo

Global Interventional Cardiology Market 2017-2021

Global Interventional Cardiology Market 2017-2021

About Interventional Cardiology

Interventional cardiology devices are primarily related to heart disease, and most of the heart diseases have some serious medical conditions, such as angina, congestive heart failure, and arrhythmias. These are often caused by partially blocked coronary arteries, which is the most common cause of death globally. Since the 1980s, balloon angioplasty has been the standard method for treating coronary artery disease. Coronary artery disease (CAD) blocks the artery that supplies blood to the heart. It occurs when the coronary artery is narrowed or blocked with the formation of plaque, which forms due to reasons such as cholesterol, fatty deposits, calcium, and other substances.

Technavio’s analysts forecast the global interventional cardiology market to grow at a CAGR of 7.15% during the period 2017-2021.Covered in this report

The report covers the present scenario and the growth prospects of the global interventional cardiology market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of interventional cardiovascular devices to key end-users such as hospitals and ambulatory surgical centers (ASCs).

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Interventional Cardiology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Vascular
  • Boston Scientific
  • Cordis
  • Medtronic
  • St. Jude Medical
Other prominent vendors
  • Aachen Resonance
  • Acrostak
  • Alvimedica
  • AngioScore
  • Arthesys
  • Asahi Intecc
  • AtriCure
  • B. Braun
  • Biosensors International
  • Biotronik
  • BrosMed Medical
  • C.R. Bard
  • Cardionovum
  • Coherex Medical
  • Cook Medical
  • Cardiovascular Systems
  • Elixir Medical
  • Fortimedix
  • Gadelius Medical
  • GaltNeedleTech
  • Gore Medical
  • Hexacath
  • JOTEC
  • Lepu Medical Technology
  • Medinol
  • Meril Life Sciences
  • Merit Medical Systems
  • MicroPort Scientific
  • Natec Medical
  • OptiMed
  • Reva Medical
  • SHOCKWAVE Medical
  • Simeks Medical
  • Smiths Medical
  • Spectranetics
  • STENTYS
  • Svelte medical
  • Teleflex
  • Terumo
  • Tokai Medical Products
  • US Endovascular
  • Volcano
Market driver
  • Increasing incidences of cardiac disorders and rise in older population
  • For a full, detailed list, view our report
Market challenge
  • High cost of interventional cardiology procedures
  • For a full, detailed list, view our report
Market trend
  • Emergence of bioabsorbable stents
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Interventional Cardiology Market 2017-2021

Technavio recognizes the following companies as the key players in the global interventional cardiology market: Abbott Vascular, Boston Scientific, Cordis, Medtronic, and St. Jude Medical

Other Prominent Vendors in the market are: Aachen Resonance, Acrostak, Alvimedica, AngioScore, Arthesys, Asahi Intecc, AtriCure, B. Braun, Biosensors International, Biotronik, BrosMed Medical, C.R. Bard, Cardionovum, Coherex Medical, Cook Medical, Cardiovascular Systems, Elixir Medical, Fortimedix, Gadelius Medical, GaltNeedleTech, Gore Medical, Hexacath, JOTEC, Lepu Medical Technology, Medinol, Meril Life Sciences, Merit Medical Systems, MicroPort Scientific, Natec Medical, OptiMed, Reva Medical, SHOCKWAVE Medical, Simeks Medical, Smiths Medical, Spectranetics, STENTYS, Svelte medical, Teleflex, Terumo, Tokai Medical Products, US Endovascular, and Volcano

Commenting on the report, an analyst from Technavio’s team said: “The introduction of new stents, such as biodegradable scaffolds, bioabsorbable polymers, and bifurcation stents, is projected to increase the utilization of stents in CADs. These stents have the potential to eliminate the negative issues of long-lasting polymer stents, which will prompt a significant shift in the treatment of conditions such as atherosclerosis, stenosis or fibrous disease. The conception of bioabsorbable stents has created interest since the past 20 years and the latest advances with the stent dissolving from the treated site with improved lesion have resulted in better enhancement in the treatment with the help of imaging, such as magnetic resonance and computed tomography. Also, these stents have the potential of allowing the vessel growth that does not require surgical removal. The vast application area will encourage patients to undergo stent implantation surgery.”

According to the report, there has been an increase in the incidence and prevalence of cardiac diseases, globally, with the sudden cardiac arrest being the leading cause of death among individuals aged above 40. The rise in vascular disorders has led to an increased sales of access devices in treating cardiac and peripheral disorders. According to CDC, every year, about 8.5 million people in the US aged above 60 suffer from PAD, which is a result of plaque formation in peripheral arteries (leg or pelvis). In the US, about 102,600 PCI procedures were performed in 2015, and these numbers have doubled over the last two years. In 2015, about 18.66 million vascular guide wires units were in demand with coronary guide wires accounting for 14.13 million units and peripheral guide wires with 4.53 million units.

Further, the report states that regulatory bodies have imposed a stringent labeling requirement, and regulatory framework for interventional cardiology devices, such as coronary stents, PTCA catheters, atherectomy devices, LAA closure or occlusion devices as their use leads to various complications. Medical devices are considered to have high risks involved and need to undergo safety examinations to demonstrate medical efficacy before being approved by regulatory agencies. Interventional cardiology devices are Class III devices and require extended clinical trials and PMA applications. Strict product approval processes and safety regulations make it difficult for manufacturers to launch new products in the market. In the US, interventional cardiology devices need to fulfill the US FDA regulations that govern all medical devices. The US FDA prevents unsafe and ineffective devices from entering or remaining in the market. Stringent US FDA regulations have delayed the approval of many products.

Companies Mentioned

Abbott Vascular, Boston Scientific, Cordis, Medtronic, St. Jude Medical, Aachen Resonance, Acrostak, Alvimedica, AngioScore, Arthesys, Asahi Intecc, AtriCure, B. Braun, Biosensors International, Biotronik, BrosMed Medical, C.R. Bard, Cardionovum, Coherex Medical, Cook Medical, Cardiovascular Systems, Elixir Medical, Fortimedix, Gadelius Medical, GaltNeedleTech, Gore Medical, Hexacath, JOTEC, Lepu Medical Technology, Medinol, Meril Life Sciences, Merit Medical Systems, MicroPort Scientific, Natec Medical, OptiMed, Reva Medical, SHOCKWAVE Medical, Simeks Medical, Smiths Medical, Spectranetics, STENTYS, Svelte medical, Teleflex, Terumo, Tokai Medical Products, US Endovascular, Volcano.

  • Executive summary
  • Scope of the report
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Causes of vascular diseases
      • Table Overview of stents used in cardiovascular interventions
      • Table Features of guide wires
      • Table Comparison of materials used in PTCA catheters
    • Market snapshot
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global interventional cardiology market 2016-2021 ($ billions)
      • Table Global interventional cardiology market: Market analysis
      • Table Global interventional cardiology market: Metrics analysis 2016 and 2021
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product type
    • Table Global interventional cardiology market segmentation by product type
    • Coronary stents
    • PTCA balloon catheters
    • Interventional guide wires
    • Interventional cardiology imaging systems
    • LAA closure devices
    • Atherectomy devices
      • Table Global interventional cardiology market segmentation by product type 2016
      • Table Global interventional cardiology market segmentation by product type 2021
  • Global coronary stents market
    • Market overview
    • Market size and forecast
      • Table Global coronary stents market 2016-2021 ($ billions)
      • Table Global coronary stents market segmentation by category
      • Table Segmentation of global coronary stents market by stent type 2016 (%)
  • Global interventional cardiology PTCA balloon catheter market
    • Market overview
    • Market size and forecast
      • Table Global interventional cardiology PTCA balloon catheters market 2016-2021 ($ billions)
      • Table Global interventional cardiology PTCA balloon catheters market segmentation by category
      • Table Segmentation of global interventional cardiology PTCA balloon catheters market by product type 2016 (%)
  • Global interventional cardiology guide wires market
    • Market overview
    • Market size and forecast
      • Table Global interventional cardiology guide wires market 2016-2021 ($ billions)
  • Global interventional cardiology imaging systems markets
    • Market overview
      • Table Global interventional cardiology imaging systems segmentation by product
    • Market size and forecast
      • Table Global interventional cardiology imaging systems market 2016-2021 in ($ billions)
      • Table Global interventional cardiology imaging systems segmentation by product type 2016 (%)
  • Global LAA closure devices market
    • Market overview
    • Market size and forecast
      • Table Global LAA closure devices market 2016-2021 ($ millions)
      • Table Global LAA closure devices segmentation by product
  • Global atherectomy devices
    • Market overview
    • Market size and forecast
      • Table Global atherectomy devices market 2016-2021 ($ millions)
      • Table Global interventional cardiology market analysis 2016
      • Table Global interventional cardiology market segmentation by product type 2016-2021 ($ billions)
      • Table Global interventional cardiology market segmentation by product type 2016-2021 (%)
  • Market segmentation by end-user
    • Table Global interventional cardiology market segmentation by end-user 2016
    • ASCs
      • Table Comparison of reimbursement for ASCs, hospital outpatient departments, and physicians' offices in the US
    • Hospitals
    • Physicians' offices
  • Geographical segmentation
    • Table Segmentation of global interventional cardiology market by geography 2016-2021 (%)
    • Interventional cardiology market in Americas
      • Table Interventional cardiology market in Americas 2016-2021 in ($ billions)
    • Interventional cardiology market in EMEA
      • Table Interventional cardiology market in EMEA 2016-2021 in ($ billions)
    • Interventional cardiology market in APAC
      • Table Interventional cardiology market in APAC 2016-2021 in ($ billions)
      • Table Segmentation of global interventional cardiology market by geography 2016-2021 ($ billions)
      • Table Segmentation of global interventional cardiology market by geography 2016-2021 (%)
  • Market drivers
    • Increasing incidences of cardiac disorders and rise in older population
      • Table Estimated percentage of aging population (aged above 50) in 2012 and 2050
    • Advances in technology
    • Growing demand for MI procedures
    • Favorable reimbursement policies
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of interventional cardiology procedures
    • Complications associated with usage of interventional cardiology devices
    • Stringent regulation for approval of devices
    • Pricing pressure coupled with lack of product differentiation
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Emergence of bioabsorbable stents
      • Table List of few bioabsorbable coronary stents approved or in approval stage in the US and Europe
    • Increase in M&A
      • Table Some of the notable M&As
    • Growing popularity of hybrid procedures
    • Focus on emerging countries
  • Vendor landscape
    • Competitive scenario
      • Table Global interventional cardiology market: Strategic success factors of companies
      • Table Competitive structure analysis of global interventional cardiology market 2015
      • Table Market penetration of various manufacturers of interventional cardiology market 2016
  • Key vendor analysis
    • Abbott Vascular
      • Table Abbott Vascular : Profile
      • Table Abbott Vascular: Strength analysis
      • Table Abbott Vascular: Growth strategy matrix
      • Table Abbott Vascular: Opportunity assessment
    • Boston Scientific
      • Table Boston Scientific: Profile
      • Table Boston Scientific: Strength analysis
      • Table Boston Scientific: Growth strategy matrix
      • Table Boston Scientific: Opportunity assessment
    • Cordis
      • Table Cordis: Profile
      • Table Cordis: Strength analysis
      • Table Cordis growth: Strategy matrix
      • Table Cordis: Opportunity assessment
    • Medtronic
      • Table Medtronic: Profile
      • Table Medtronic: Strength analysis
      • Table Medtronic: Growth strategy matrix
      • Table Medtronic: Opportunity assessment
    • St. Jude Medical
      • Table St. Jude Medical: Profile
      • Table St. Jude Medical: Strength analysis
      • Table St. Jude Medical: Growth strategy matrix
      • Table St. Jude Medical: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report